Escalation Watch

Is Escalation Watch a prediction of future FDA action?

No. Escalation Watch is descriptive only — it reports patterns already on file (a warning letter and a Form 483 both recorded, multiple 483s within 12 months, or a broader repeat-action history). It does not forecast whether any company will face future FDA action.

What counts as a "warning letter + Form 483" pattern?

A company where our database has at least one FDA warning letter and at least one Form 483 inspection observation on file, indicating both an inspection finding and a subsequent enforcement letter exist in the record for the same firm.

What counts as a "repeat pattern"?

Three or more total FDA actions (warning letters, recalls, 483s, or approvals combined) on file for a single company across our tracked database — a descriptive count of enforcement volume, not a severity or risk score.

How often is this list updated?

The underlying company_event_rollup data refreshes as our daily FDA ingestion pipeline processes new warning letters, recalls, 483s, and approvals, so this page reflects current database state on each load.

Does Escalation Watch cover every company the FDA has ever cited?

No — it covers only companies within Argus HQ’s tracked database, which reflects our ingestion window rather than the complete history of FDA enforcement. See data sources for coverage details.

Can I get this delivered instead of checking the page manually?

Yes — the Briefing Desk paid tier delivers a curated daily digest of escalation-worthy FDA actions across your own watchlist, rather than requiring a manual check of this public page.